Case Study: Can Cultivated Meat Revolutionise Biologic Manufacturing

Cell-cultured meat production is increasing, predicting to reach $1.1 billion in value by 2034. Though not the usual modality, various companies in the life science industry have expanded their interest and activity to cell-cultured meat research and manufacturing because of the similarity in equipment and expertise required._x000D_ _x000D_ _x000D_ _x000D_ • Exploring existing biomanufacturing facilities setup and the possibility to adapt cultivated meat production_x000D_ _x000D_ • Comparing the regulatory frameworks for biologics and cultivated meat, highlighting key differences and potential challenges._x000D_ _x000D_ • Assessing the possibility of using cultivated meat technology to manufacture specific proteins or biomaterials for therapeutic purposes._x000D_ _x000D_ • Looking at the potential opportunities and challenges of scaling cultivated meat production to meet market demands compared to smaller-scale biopharmaceutical production.